Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2444816
Reference Type
Journal Article
Subtype
Review
Title
CORTICOSTEROIDS AND CROMOLYN SODIUM AS MODULATORS OF AIRWAY INFLAMMATION
Author(s)
Mcfadden, ER
Year
1988
Is Peer Reviewed?
Yes
Journal
Chest
ISSN:
0012-3692
EISSN:
1931-3543
Volume
94
Issue
1
Page Numbers
181-184
Language
English
PMID
3133163
DOI
10.1378/chest.94.1.181
Web of Science Id
WOS:A1988P190000041
Abstract
Heightened airway reactivity is a cardinal feature of asthma and correlates with many clinical features of the illness, such as the acute response to bronchodilator drugs, the magnitude of diurnal fluctuations in lung function, and the amount of therapy required to control symptoms. Data have accumulated indicating that a reduction in airway reactivity can decrease asthma morbidity, and many advocate treating asthmatic patients prophylactically to prevent acute exacerbations from developing, rather than responding to them after they have occurred. This approach is particularly effective if it is used when the airways are being exposed to stimuli to which they are sensitive. A number of drugs have been purported to reduce airway reactivity, but the most convincing evidence supports the effects of cromolyn and inhaled and oral steroids. Although each type of drug has its own advantages and disadvantages and different modes of action, the common denominator is believed to be a reduction in the state of airway inflammation.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity